Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Design Therapeutics, Inc. (DSGN) had Weighted-Average Shares Outstanding (Basic) of 56.86M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-19.08M |
|
-- |
|
-- |
|
$21.57M |
|
$-21.57M |
|
$2.49M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-19.08M |
|
$-21.57M |
|
$-22.33M |
|
|
Weighted-Average Shares Outstanding (Basic) |
56.86M |
56.86M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$219.79M |
|
$1.26M |
|
$3.09M |
|
$222.89M |
|
$8.75M |
|
-- |
|
$1.10M |
|
$9.85M |
|
$213.04M |
|
$213.04M |
|
$213.04M |
|
56.95M |
|
| Cash Flow Statement Financials | |
$-31.23M |
|
$27.99M |
|
$0.38M |
|
$22.56M |
|
$19.70M |
|
$-2.86M |
|
$7.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.96% |
|
-8.96% |
|
-8.56% |
|
-8.96% |
|
$3.74 |
|
$-0.55 |
|
$-0.55 |
|